Basal epithelial stem cells are efficient targets for prostate cancer initiation - Wikidata - wikimedia - TriplyDB

Basal epithelial stem cells are efficient targets for prostate cancer initiation

Basal epithelial stem cells are efficient targets for prostate cancer initiation

http://www.wikidata.org/entity/Q33664410

about

Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells Identification of a cell of origin for human prostate cancer Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling Prostate cancer stem cells: the role of androgen and estrogen receptors Stem cells in genetically-engineered mouse models of prostate cancer The many ways to make a luminal cell and a prostate cancer cell The androgen receptor and stem cell pathways in prostate and bladder cancers (review)Targeting prostate cancer stem cells for cancer therapy Prostate cancer and parasitism of the bone hematopoietic stem cell niche High milk consumption does not affect prostate tumor progression in two mouse models of benign and neoplastic lesions Actions of estrogens and endocrine disrupting chemicals on human prostate stem/progenitor cells and prostate cancer risk CXCR4 expression in prostate cancer progenitor cells Estrogen-initiated transformation of prostate epithelium derived from normal human prostate stem-progenitor cells A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.Minireview: prolactin regulation of adult stem cells Essential roles of epithelial bone morphogenetic protein signaling during prostatic development.The molecular basis for ethnic variation and histological subtype differences in prostate cancer.Lineage relationship of prostate cancer cell types based on gene expression GLI1 confers profound phenotypic changes upon LNCaP prostate cancer cells that include the acquisition of a hormone independent state Clonal architecture of human prostatic epithelium in benign and malignant conditions.Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors.Primitive origins of prostate cancer: in vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells Molecular genetics of prostate cancer: new prospects for old challenges Luminal cells are favored as the cell of origin for prostate cancer Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epithelium.Single luminal epithelial progenitors can generate prostate organoids in culture.Elimination of head and neck cancer initiating cells through targeting glucose regulated protein78 signaling Cellular origin of bladder neoplasia and tissue dynamics of its progression to invasive carcinoma Estrogen receptor β activation impairs prostatic regeneration by inducing apoptosis in murine and human stem/progenitor enriched cell populations.Molecular pathways and targets in prostate cancer Identification of CD166 as a surface marker for enriching prostate stem/progenitor and cancer initiating cells CD49f is an efficient marker of monolayer- and spheroid colony-forming cells of the benign and malignant human prostate Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor A Tale of Two Signals: AR and WNT in Development and Tumorigenesis of Prostate and Mammary Gland.Induced pluripotency of human prostatic epithelial cells.Antitumor Efficacy of the Dual PI3K/mTOR Inhibitor PF-04691502 in a Human Xenograft Tumor Model Derived from Colorectal Cancer Stem Cells Harboring a PIK3CA Mutation.Purification and direct transformation of epithelial progenitor cells from primary human prostate.Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signal.Prostate adenocarcinomas aberrantly expressing p63 are molecularly distinct from usual-type prostatic adenocarcinomas.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.

P2860

Q24302022-4F699BE5-D28D-4213-B529-24FF3CDF4359 Q24594400-07907D99-FD67-4CF6-9617-046E8CC831E2 Q24629299-B4CA1D14-E0E1-4B43-A2C3-FD8774053B8F Q26778415-FB3A2AE0-0FE6-49C7-8674-EFC97F658CDC Q26784057-5B7F318D-B610-4C3E-97FD-14E57380D79C Q26797386-C013FBA3-C2E2-41B7-A6AB-D93B6A2F3497 Q26853232-AD68F6BF-ABAA-4B2A-B2E2-C6B94A283734 Q26865693-DD7A6658-DAC9-4C98-B897-B7C3B38D17DC Q26996231-9D46BCB4-07C5-4CDA-A472-711E03F48A8B Q27308667-9EF7316A-5B16-4752-88B2-50C16D6A1071 Q28395212-E9A40353-CAC3-4052-B3DD-A6A3F4516F09 Q28480904-89B36629-8CC4-475F-AA85-EA4C3A50C25D Q30426649-8D034DFE-C136-4C9A-8BB2-E1C2A4AA9595 Q30504566-BCA9837D-C83C-42DB-BFFC-E1F9422743A0 Q33631708-9BDB7281-97AC-418C-A63A-67FD301EA104 Q33765462-E90B947B-7A22-46FA-9A1D-87EF1A73EF56 Q33835864-5BD1F30C-A5E8-4640-99F9-11763169478F Q33909346-CA3EA33C-25C1-449A-97F4-90E59E5531FE Q33919758-D86AC694-A5EA-4235-9BC9-332DC76F5757 Q34013183-5F8EF43A-E990-4BAB-AD02-A0646DFEA7E5 Q34093594-8ECBD941-C6C6-4E5B-8E97-8C8F1C4EBC33 Q34126555-519545C2-4171-4006-9516-BEEE32444305 Q34127462-AF8E5EBB-3E44-40A1-A97C-18EDCC12C760 Q34175508-E4A74EF5-80EF-4184-B86B-12FF958F2A24 Q34182662-1D29A00A-8572-46A6-8C85-8880969A38D5 Q34282951-406FE615-22B7-4DE8-A14B-8EC5F39D8E4C Q34331960-8886FE13-F731-4F5F-BDEE-2F219604E1F3 Q34338401-65A151BE-1028-4F5B-B8D2-556A2B9971D7 Q34342340-B0049FE3-3AC4-43CC-84A8-EA17477CD2F6 Q34365632-864911A7-5CA2-425D-B3BC-B1E1B416CAD0 Q34374335-279AB4DF-153B-4535-A5AE-5110E8BE7477 Q34447710-0A75FFCD-CC76-4D91-B9B4-1BE7C798ACB6 Q34473795-6BE80DF3-3F36-4FA2-A7F6-ED00F6FED622 Q34550256-8B75BEBB-F83F-4791-B4DC-51CB83E6D256 Q34745924-BF942A30-F6E1-4E4B-A68B-04154AD93042 Q34796781-9E39BD32-8796-4287-97CA-443D1F120688 Q34974257-16D44142-5DA9-47B5-91D1-8A2DB0039C8F Q34978001-6B823ABA-7347-4A7A-B485-DD7533B894EE Q35132292-A952D5C6-84AB-499E-84C8-1356ECE4A134 Q35287094-F25EBF3C-7903-4A38-ADFC-04848012A67B

P2860

Basal epithelial stem cells are efficient targets for prostate cancer initiation

http://www.wikidata.org/entity/Q33664410

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Basal epithelial stem cells are efficient targets for prostate cancer initiation

@ast

Basal epithelial stem cells are efficient targets for prostate cancer initiation

@en

type

label

Basal epithelial stem cells are efficient targets for prostate cancer initiation

@ast

Basal epithelial stem cells are efficient targets for prostate cancer initiation

@en

prefLabel

Basal epithelial stem cells are efficient targets for prostate cancer initiation

@ast

Basal epithelial stem cells are efficient targets for prostate cancer initiation

@en

P1433

Q33664410-2906A4C4-0214-40D7-A337-87B041F58660

P1476

Q33664410-871DD1D2-7DE7-4B1F-8467-F7B9FE427DAE

P2093

Q33664410-0C0BAC65-22D9-4D7B-8236-2DAB37DB52CB

Q33664410-4C42A880-1F03-4831-887C-D01A1485DA92

Q33664410-5F33AECD-3F94-4004-A37F-697CEC43AB51

Q33664410-C3FF8DC3-95D6-4C14-9259-E987DCF1B0F2

Q33664410-E19E7364-7CA3-4597-AB08-E0E3133D1A57

Q33664410-F3B576FA-B336-4ECE-8836-D31F83782143

P2860

Q33664410-061B68E8-61D3-4EAA-B035-7A14F2619E86

Q33664410-07D99E2A-2ED1-4E72-96C6-FBE837B558DB

Q33664410-0AAFFE21-ADEB-440A-8FDB-C70BC5E1DCB5

Q33664410-0C8AAF14-8AC2-4CED-8DB6-4F631846333B

Q33664410-19B5903F-D65E-4AE9-89ED-567C194FBD15

Q33664410-3709738E-CD68-45D0-8958-EB5F3148C85C

Q33664410-385032E1-27C2-403D-BEA5-EAB056321247

Q33664410-3C535E59-A3F7-4FA3-B2F9-613D362271E8

Q33664410-600281C9-6C1C-4158-B45D-98127ACC4A6A

Q33664410-683B0475-38F8-4F4E-ADCC-E09C7066D05F

P304

Q33664410-D591C22D-767F-4F6F-BCFC-7FF0314567EB

P31

Q33664410-6A1FBBC6-E94D-48EB-8CA6-E31229B0A157

P356

Q33664410-486F93A1-28FE-4102-BE54-ED72C43521EC

P407

Q33664410-6F281FBA-33C2-4B21-888D-D5E4FBBA02E3

P433

Q33664410-18C5EA8D-584C-489E-8A38-DD38D6441F13

P478

Q33664410-64B98250-0CA9-4957-AE25-3EC2E51CB82B

P577

Q33664410-9023FAFC-0DFA-4062-9B45-8D0810AEEEC6

P5875

Q33664410-E317C00B-8954-4D21-A1D5-D6526AF8AD2C

P698

Q33664410-94FFAEBC-BBEC-460A-98CC-91CADAA67FD5

P932

Q33664410-6EA4630E-A8CF-4D07-9113-FC31FB4AEE8A

P356

PNAS.0913873107

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Basal epithelial stem cells are efficient targets for prostate cancer initiation

@en

P2093

Devon A Lawson

http://www.w3.org/2001/XMLSchema#string

Jiaoti Huang

http://www.w3.org/2001/XMLSchema#string

Li Xin

http://www.w3.org/2001/XMLSchema#string

Owen N Witte

http://www.w3.org/2001/XMLSchema#string

Sanaz Memarzadeh

http://www.w3.org/2001/XMLSchema#string

Yang Zong

http://www.w3.org/2001/XMLSchema#string

P2860

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Role of the TMPRSS2-ERG gene fusion in prostate cancer

Crypt stem cells as the cells-of-origin of intestinal cancer

FGF-10 plays an essential role in the growth of the fetal prostate

The development of androgen-independent prostate cancer

Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model

The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis

PTEN, a unique tumor suppressor gene.

Enhanced paracrine FGF10 expression promotes formation of multifocal prostate adenocarcinoma and an increase in epithelial androgen receptor

Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation

P304

2610-2615

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0913873107

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

107

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41408658

http://www.w3.org/2001/XMLSchema#string

P698

20133806

http://www.w3.org/2001/XMLSchema#string

P932

2823887

http://www.w3.org/2001/XMLSchema#string